top of page
liquidscreenlung_hero.jpg

50%

of EGFR NSCLC patients on 1st line TKIs develop EGFR resistance mutations (p.T790M) [1].

liquidscreenlung_about.jpg

LiquidSCREEN Lung is a polymerase chain reaction (PCR) blood test. It detects EGFR mutations and monitors changes to detect resistance mutations in Non-Small Cell Lung Cancer (NSCLC) patients.

The test can be used at: 

  • initial diagnosis to inform treatment selection

  • follow-up for relapse or resistance monitoring

​
Available internationally outside the USA. 

Gene List

  • Sensitizing targets: 

    Exon 18: G719A, G719C, G719S 

    Exon 19: E746_A750del, L747_P753delinsS, L747_A750delinsP, L747_T751del 

    Exon 21: L858R, L861Q 
     

  • Resistance targets:
    T790M

References:

  1. Kobayashi, S. et al. N Engl J Med. 352(8):786-792, 2005.

Order a Test Kit

bottom of page